| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 6.617 | 13.934 | 15.960 | 14.347 | 15.880 | 14.482 |
| Total Income - EUR | - | - | - | - | 7.644 | 18.328 | 19.898 | 18.297 | 19.819 | 18.399 |
| Total Expenses - EUR | - | - | - | - | 6.294 | 16.447 | 10.581 | 11.468 | 12.759 | 17.998 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.350 | 1.880 | 9.318 | 6.829 | 7.060 | 401 |
| Net Profit/Loss - EUR | - | - | - | - | 1.284 | 1.779 | 9.317 | 6.707 | 6.901 | 257 |
| Employees | - | - | - | - | 1 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Monmedact S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 31.484 | 26.859 | 22.325 | 18.443 | 14.449 | 10.451 |
| Current Assets | - | - | - | - | 3.000 | 4.546 | 13.141 | 13.602 | 8.721 | 4.553 |
| Inventories | - | - | - | - | 198 | 194 | 190 | 190 | 190 | 709 |
| Receivables | - | - | - | - | 0 | 8 | 282 | 262 | 218 | 217 |
| Cash | - | - | - | - | 2.803 | 4.344 | 12.670 | 13.149 | 8.313 | 3.627 |
| Shareholders Funds | - | - | - | - | 1.326 | 3.080 | 12.329 | 12.991 | 6.950 | 305 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 9.523 | 1.466 | 812 | 611 | 1.771 | 4.248 |
| Income in Advance | - | - | - | - | 23.635 | 26.859 | 22.325 | 18.443 | 14.449 | 10.451 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Monmedact S.r.l.